SAN JOSE, Calif., Oct. 29, 2018 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body\'s immune system to fight cancer, today announced that it will present data from its ongoing studies utilizing Cchek™, Anixa\'s artificial intelligence...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]-annual-meeting-300738903.html